Xoma | XOMA - Przychody Ze Sprzedaży





Obroty Zmiana Data
AbbVie USD 16.62B 840M 2025-12
Agenus USD 34.2M 3.97M 2025-12
Agios Pharmaceuticals USD 19.97M 7.07M 2025-12
Ardelyx USD 125.21M 14.89M 2025-12
aTyr Pharma USD 110.08M 109.89M 2025-12
BioMarin Pharmaceutical USD 875M 99M 2025-12
Celldex Therapeutics USD 121K 769K 2025-12
Curis USD 1.14M 1.41M 2025-12
Eli Lilly USD 19.3B 1.7B 2025-12
Emergent BioSolutions USD 276.6M 6.1M 2023-12
Incyte USD 1.51B 140M 2025-12
MacroGenics USD 41.23M 31.61M 2025-12
Novartis USD 13.86B 50M 2025-12
Novartis USD 13.86B 498M 2025-12
Pfizer USD 17.58B 880M 2025-12
Prothena USD 21K 2.4M 2025-12
Regeneron Pharmaceuticals USD 3.88B 130M 2025-12
Xoma USD 25K 5M 2024-09